XML 26 R15.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 9 - Segment Information
 9 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note
9
-
Segment Information
 
As of
March
31,
2016,
our
four
operating segments were Biological Indicators, Instruments, Continuous Monitoring and Cold Chain. Effective
April
1,
2016
we renamed our Continuous Monitoring and Cold Chain operating segments to Cold Chain Monitoring and Cold Chain Packaging, respectively. In addition, we transferred certain of the Cold Chain monitoring and other services to our Cold Chain Monitoring operating segment (historically included in our cold chain operating segment) to align with the information being used by the chief decision maker of the Company. Accordingly, all prior period segment information presented herein has been adjusted to reflect this change in our organization structure. The following tables set forth our segment information (in thousands):
 
 
 
Three Months Ended December 31
, 2016
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Cold Chain Monitoring
 
 
Cold Chain
Packaging
 
 
Total
 
Revenues
   $
9,248
     $
9,013
     $
3,102
     $
2,480
     $
23,843
 
                                         
Gross profit
   $
6,066
     $
5,706
     $
1,254
    $
511
      
13,537
  
Reconciling items
(1)
    
 
      
 
      
 
      
 
      
(9,657
 )
Earnings before income taxes
    
 
      
 
      
 
      
 
     $
3,880
 
 
 
 
Three Months Ended December 31
, 2015
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Cold Chain Monitoring
 
 
Cold Chain
Packaging
 
 
Total
 
Revenues
   $
7,819
     $
8,260
     $
2,853
     $
981
     $
19,913
  
                                         
Gross profit
   $
4,869
     $
5,511
     $
1,313
    $
516
     
12,209
  
Reconciling items
(1)
    
 
      
 
      
 
      
 
      
(8,758
 )
Earnings before income taxes
    
 
      
 
      
 
      
 
     $
3,451
  
 
 
 
Nine Months Ended December 31
, 2016
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Cold Chain Monitoring
 
 
Cold Chain
Packaging
 
 
Total
 
Revenues
   $
27,612
     $
25,928
     $
8,964
     $
6,862
     $
69,366
 
                                         
Gross profit
   $
17,986
     $
15,881
     $
3,578
    $
1,830
      
39,275
  
Reconciling items
(1)
    
 
      
 
      
 
      
 
      
(30,014
 )
Earnings before income taxes
    
 
      
 
      
 
      
 
     $
9,261
 
 
 
 
Nine Months Ended December 31
, 2015
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Cold Chain Monitoring
 
 
Cold Chain
Packaging
 
 
Total
 
Revenues
   $
23,537
     $
25,819
     $
7,954
     $
2,537
     $
59,847
  
                                         
Gross profit
   $
15,157
     $
16,571
     $
3,326
     $
1,363
     
36,417
  
Reconciling items
(1)
    
 
      
 
      
 
      
 
      
(26,647
 )
Earnings before income taxes
    
 
      
 
      
 
      
 
     $
9,770
  
 
(1)
Reconciling items include selling, general and administrative, research and development, and other expenses
 
 
 
December 31, 2016
 
 
March 31,
201
6
 
Total assets (in thousands):
                
Biological Indicators
   $
67,894
    $
56,724
  
Instruments
    
38,295
      
49,077
  
Cold Chain Monitoring
    
35,497
      
27,613
  
Cold Chain Packaging
    
21,325
      
19,478
  
Corporate and administrative
    
7,442
      
7,856
  
    $
170,453
     $
160,748
  
 
All long-lived assets are located in the United States except for
$6,460,000
and $
20,702,000
which are associated with our French and Canadian subsidiaries, respectively.
 
Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):
 
 
 
Three
M
onths
E
nded
December 31
,
 
 
Nine Months Ended
December 31,
 
 
 
201
6
 
 
2015
 
 
2016
 
 
2015
 
Net revenues from unaffiliated customers:
                                
United States
   $
13,844
    $
12,787
     $
44,758
    $
37,510
  
Foreign
    
9,999
      
7,126
      
24,608
      
22,337
  
    $
23,843
    $
19,913
     $
69,366
    $
59,847
  
 
No foreign country exceeds
10
percent of total revenues.